Imatinib Resistance Mutation Analysis IRMA Test
Introduction
The Imatinib Resistance Mutation Analysis IRMA Test is an advanced diagnostic tool designed to detect specific mutations in the BCR-ABL gene associated with resistance to imatinib therapy in patients with chronic myeloid leukemia (CML). As CML treatment evolves, understanding the genetic landscape of the disease becomes paramount. This test plays a crucial role in guiding oncologists in making informed treatment decisions, ultimately improving patient outcomes.
What the Test Measures
This test analyzes the BCR-ABL fusion gene for mutations that may lead to resistance against imatinib, a common medication used in the treatment of CML. By identifying these mutations, healthcare providers can tailor treatment plans to enhance efficacy and minimize the risk of disease progression.
Who Should Consider This Test
Patients diagnosed with chronic myeloid leukemia (CML) who are currently undergoing imatinib therapy or have experienced a relapse should consider the Imatinib Resistance Mutation Analysis IRMA Test. Symptoms indicating the need for this test may include:
- Persistent or worsening symptoms of CML
- Suboptimal response to imatinib therapy
- Recent changes in blood counts
Additionally, individuals with known risk factors for CML should also discuss this test with their oncologist.
Benefits of Taking the Test
- Identifies mutations that may affect treatment efficacy.
- Guides oncologists in personalizing treatment plans.
- Helps in monitoring disease progression and response to therapy.
- Provides peace of mind for patients and their families.
Understanding Your Results
Results from the Imatinib Resistance Mutation Analysis IRMA Test are typically available within one week. Your healthcare provider will explain the findings and their implications for your treatment plan. Understanding whether mutations are present can significantly influence the choice of therapy moving forward.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Imatinib Resistance Mutation Analysis IRMA Test | 21,000 KSh | 20,280 KSh |
How to Book the Test
We have branches across Kenya, making it convenient for you to access our services. To book the Imatinib Resistance Mutation Analysis IRMA Test, please call or WhatsApp us at +254711564616. Our team is ready to assist you with any inquiries and guide you through the booking process.
Additional Information
Turnaround Time: Sample must be submitted by Monday 11 am; report available by Saturday.
Sample Type: 4 mL (2 mL minimum) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Submit the latest BCR-ABL Quantitative report along with the sample.
Pre-Test Instructions: Please ensure to submit the latest BCR-ABL Quantitative report along with your sample for accurate results.
Specialty: Oncologist
Department: Molecular Diagnostics
Method: PCR, Sequencing
Disease Type: Pharmacogenomics
